Business Wire

PA-PENNENGINEERING

22.7.2024 09:01:33 CEST | Business Wire | Press release

Share
PennEngineering® Expands Galway, Ireland Facility to Create 70 New Jobs

PennEngineering® a global leader in innovative fastening solutions, has announced the expansion of its operations located in Galway City, Ireland.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240722804353/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

(Photo: Business Wire)

This significant extension is set to create 70 new jobs over the next five years, in support of the company's commitment to growth and community development.

The €14 million expansion project, which involves the construction of a new building, includes a state-of-the-art technology and training centre as well as testing laboratories and customer experience centre that will enhance PennEngineering’s capacity to meet the increasing demand for engineering fastening solutions. The new jobs created will span a variety of roles, including manufacturing, engineering, training and more, offering diverse opportunities for local talent.

The expansion project is supported by the Irish Government through IDA Ireland.

Minister of State for Trade Promotion, Digital and Company Regulation, Dara Calleary TD said: “I am pleased to welcome this announcement from PennEngineering which will see the creation of 70 jobs as part of a major expansion project. Investments such as this continue to advance Galway’s position, in particular, as a global hub. I am pleased to welcome this announcement and wish PennEngineering every success.”

“We are thrilled to expand our operations in Galway,” said Mary Ann Fleming, President, PennEngineering Europe. “This investment reflects our confidence in the potential for growth in the region and our commitment to contributing to the local economy. We look forward to welcoming new members to our team and continuing to innovate in the world of fastening technology. Our on-site manufacturing also continues to expand with the introduction of new products, continuing our 82-year history of product innovation in self-clinch fasteners. Supporting training and development of our people and job creation are priorities for us, and this expansion is key to this initiative. As part of this growth announcement, we welcome the board of PennEngineering on site for their biannual meeting and wish them well as they strategise for the future of our global company.”

“Our long-standing partnership with Ireland and the IDA spans over 20 years, and their support has been invaluable in fostering the growth and development of our business in Europe,” according to Pete George, PennEngineering CEO.

The expansion is expected to be completed by January 2025. PennEngineering plans to begin the recruitment process immediately, with job openings to be posted on the company’s website and local job boards.

Mary Buckley, Executive Director of IDA Ireland, said: “PennEngineering has been in Galway since 2001, and this announcement today highlights their ongoing commitment to the West Region. The operation is already a recognised centre of excellence within the global organisation and this 4000m² expansion and 70 jobs further enhances its strategic capabilities in Galway. I wish the PennEngineering team continued success.”

For more information about the expansion and job opportunities, please visit www.pemnet.com/eu/.

About PennEngineering: https://www.penn-eng.com/

Since 1942, PennEngineering® has enjoyed a sustained reputation as the global leader in the fastening industry. The company's brands, PEM®, PROFIL®, Sherex®, PennAuto®, are considered the premier manufacturer for self clinching and other mechanically attached fasteners. Haeger®, for installation systems and Heyco® for molded and stamped products.

PennEngineering’s steadfast commitment to engineering expertise and global innovation ensures that we continue to grow our portfolio with technologies and solutions that allow our customers to not only keep pace with marketplace challenges – but exceed them.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240722804353/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Kubota Vision Inc. Signs Supply and Licensing Agreement with Laboratoires KÔL for Stargardt Disease Treatment Candidate Under Compassionate Use4.5.2026 17:16:00 CEST | Press release

Kubota Vision Inc. (“Kubota Vision”), a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Minato-ku, Tokyo, Japan) announced signing of a Supply and Licensing Agreement with Laboratoires KÔL (Clermont-Ferrand, France) for the provision of a Stargardt disease (STGD1) treatment candidate under compassionate use authorization. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260414590785/en/ The purpose of this Agreement is for Kubota Vision and KÔL to collaborate on providing “Emixustat” for treatment of Stargardt Disease (STGD1) through compassionate use authorization in France. Kubota Vision will exclusively manufacture and supply Emixustat final products to KÔL and KÔL will have exclusive rights to distribute Emixustat in France under compassionate use access. Ryo Kubota, Chairman, President, and CEO of Kubota Pharmaceutical Holdings, stated, “We are extremely pleased to enter into this Agreement with Labor

Incentive Market Set to Surpass $80B by 2030s — IMA Launches Tools to Help the Industry Keep Pace4.5.2026 16:28:00 CEST | Press release

With combined business spend on loyalty, employee recognition, and channel incentives projected to exceed $80 billion by the 2030s, the incentive industry is entering a period of rapid scale and strategic pressure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260422729016/en/ In response, the Incentive Marketing Association (IMA) launched a new suite of resources designed to help incentive professionals navigate an environment that’s becoming more specialized, fragmented, and central to business performance. “It’s not just more money coming in—it’s more complexity,” said Vince Chiofolo, President of the Incentive & Engagement Solution Providers (IESP). “Buyers are demanding programs that evolve fast, integrate deeply, and feel personal at scale. These new tools were built for that.” IMA’s Suite of Tools Includes: New Industry Report — Inside the Incentive Buyer’s Mind Drawn from insights of 50+ program owners, the report f

Tigo Energy Breaks Global Growth Benchmark; Boosts U.S. Energy Feature in Predict+4.5.2026 15:00:00 CEST | Press release

Advanced energy prediction platform adds real-time energy pricing for North American Independent System Operator (ISO) customers, accelerates meters-connected growth. Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo” or “Company”), a leading provider of intelligent solar and energy solutions, today announced that the Predict+ platform now offers integrated real-time spot market pricing for ISO customers in the United States. Predict+ provides utilities with deep insights into grid demand, renewable generation, and energy market dynamics, enhancing the precision, scalability, and robustness of energy forecasting to up to 97.5% accuracy through machine learning and artificial intelligence. For energy providers, Predict+ helps streamline operations, reduce volatility, and maximize performance. Predict+ empowers utility operators to adapt to real-world demand challenges when balancing renewable and baseload generation sources, particularly during extreme weather events and market disruptions. On th

Airship Announces 2026 Elevate Customer Experience Award Winners4.5.2026 15:00:00 CEST | Press release

Southwest Airlines, The Economist, and OneFootball among brands recognized at Elevate’26 Customer Experience Summit for setting the standard in mobile-first and AI-centered customer experiences Airship, the mobile-first customer experience company, today announced the winners of the 2026 Elevate Customer Experience Awards. Global brand leaders from The Economist, Southwest Airlines, and OneFootball were among those honored at the Elevate’26 Customer Experience Summit. The Elevate Awards spotlight global companies that have developed exceptional mobile-first customer experiences for their customers, created innovative campaigns, leveraged AI agents to reach new levels of productivity, and achieved real business results. "Evolving mobile-first consumer behaviors and unprecedented advancements in AI are driving a seismic shift that is reshaping how brands interact with their customers," said Brett Caine, CEO, Airship. "The 2026 Elevate Award winners aren’t just adapting, they’re leading t

Alnylam to Present New Analyses at Heart Failure 2026 Underscoring Consistent Clinical Profile of Vutrisiran in ATTR-CM4.5.2026 14:30:00 CEST | Press release

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced it will present new data analyses for vutrisiran in patients with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) at Heart Failure 2026, a scientific congress of the European Society of Cardiology, taking place May 9-12, 2026, in Barcelona, Spain. ATTR-CM is a heterogeneous and rapidly progressive disease, and patients often present with complex clinical profiles. At Heart Failure 2026, Alnylam will present multiple new analyses from the Phase 3 HELIOS-B study of vutrisiran, which continue to support its use as a first-line treatment for patients with ATTR-CM, and further characterize its clinical profile across patients with a high disease burden, and in the context of concomitant therapies. Vutrisiran is the first and only transthyretin (TTR) silencer for ATTR-CM that delivers rapid knockdown of TTR at the source. Additional analyses being pr

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye